BEAMER

What BEAMER does

BEAMER is a European research consortium, not a commercial company, launched in 2021 with €11.9M in funding from the Innovative Medicines Initiative (IMI) 2 Joint Undertaking under EU Horizon 2020 grant agreement No. 101034369, with co-funding from EFPIA and Link2Trials. The project brings together 28 public and private European partners across academia, civil society and industry to address treatment non-adherence, which it cites as affecting up to 50% of patients with chronic conditions and driving preventable mortality, hospitalizations and healthcare costs.

Its core product is B-COMPASS, a disease-agnostic behavioral questionnaire that segments patients into eight adherence profiles using five measurable factors — Acceptance, Control, Health Consciousness, Concerns and Health Priority. A companion digital tool, the Adherence Intelligence Visualization Platform (AIVP), is being developed for healthcare professionals to manage adherence data and has been evaluated for usability (SUS 70%), acceptance (TAM 74.25%) and trust (HCTM 67.64%). B-COMPASS is currently being validated in 3,500 patients across 18 settings and nine pilot sites in cardiology, endocrinology, immunology, neurology, oncology and rare disease, spanning the Czech Republic, Germany, Greece, Italy, the Netherlands, Norway, Portugal, Slovenia and Spain, with international collaborators in Brazil, Mexico, Tanzania, the USA, Canada and Japan.

BEAMER does not sell a product. Its business model is grant-funded public-private partnership research, with outputs — the model, the AIVP tool, and the validation evidence base — intended to benefit patients, healthcare professionals, pharmaceutical companies, regulators, payers and policymakers. Distribution occurs through scientific collaboration, peer-reviewed publications, webinars, conferences and an annual World Adherence Day campaign rather than commercial channels, and ECHAlliance (Connected Health Alliance CIC) acts as the data controller for the project.

Name

BEAMER

Legal name

BEAMER Project (managed by ECHAlliance / Connected Health Alliance CIC)

Website

https://beamerproject.eu

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

BEAMER is a publicly funded European research consortium that develops and validates B-COMPASS, a disease-agnostic behavioral model segmenting patients into eight adherence profiles to help healthcare professionals, pharmaceutical companies, regulators, payers and patients address treatment non-adherence.

Ownership category

akta.pro rank

Product category

Digital Health Adherence Technology

NAICS

Home Health Care Services (62161), Other Individual and Family Services (624190)

SIC

Services-Health Services (8000)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industries

Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL), AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM), Patient App, Adherence & Engagement for RPM Programs (HLACAFAJ), Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)

Keywords

• Treatment adherence research
• Behavioral health modeling
• Patient segmentation platform
• Digital health adherence solutions
• Pharmaceutical patient support

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

BEAMER develops the B-COMPASS model, a disease-agnostic questionnaire-based behavioral framework that segments patient populations based on five measurable factors (Acceptance, Control, Health Consciousness, Concerns, Health Priority) to predict treatment adherence and enable personalized patient support. The project also delivers the Adherence Intelligence Visualization Platform (AIVP), a digital tool for healthcare professionals to visualize and manage patient adherence data.

Product overview

BEAMER is a European health research project focused on improving treatment adherence. The core product offering consists of the B-COMPASS model, a disease-agnostic behavioral questionnaire that predicts patient adherence behavior and segments patients into eight unique adherence profiles, complemented by the Adherence Intelligence Visualisation Platform (AIVP) for healthcare professionals to visualize and manage patient adherence data. The project involves 28 public and private European partners and is funded with €11.9M by IMI.

Differentiator

Problem solved

Functional benefit

Brands

• B-COMPASS: A disease-agnostic model developed by BEAMER that segments the population based on actionable factors and predicts adherence behaviour to help build digital health solutions and promote better outcomes.

Products and services

• B-COMPASS A disease-agnostic questionnaire-based model that segments patient populations based on five actionable behavioral factors (Acceptance, Control, Health Consciousness, Concerns, Health Priority) to predict treatment adherence and enable personalized patient support. The model generates eight unique adherence profiles for healthcare professionals and pharmaceutical stakeholders.
• Adherence Intelligence Visualisation Platform (AIVP) A digital tool for healthcare professionals to manage patient treatment adherence, featuring visualization capabilities for remote care settings and evaluated for usability (SUS: 70%), acceptance (TAM: 74.25%), and trust (HCTM: 67.64%).

Quantifiable outcome

• Up to 50% of patients with chronic conditions experience treatment non-adherence
• +3 more outcomes

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Nine partnerships are on record, tiered core.

• Link2TrialscoreStrategic or Co-development PartnerLink2Trials, a clinical trial platform, is a consortium partner contributing to BEAMER's research on treatment adherence across clinical and real-world settings.
• ECHAlliance (Connected Health Alliance CIC)coreStrategic or Co-development PartnerECHAlliance manages the BEAMER project's privacy policy and data protection as the Connected Health Alliance, facilitating multi-stakeholder collaboration across healthcare ecosystems.
• Akershus University Hospital and the University of OslocoreStrategic or Co-development PartnerNorwegian pilot site conducting B-COMPASS validation studies in cardiovascular and other chronic conditions.
• Italian Multiple Sclerosis FoundationcoreStrategic or Co-development PartnerItalian pilot site validating B-COMPASS model in neurology, specifically for multiple sclerosis patient populations.
• World Duchenne OrganizationcoreStrategic or Co-development PartnerInternational organization focused on Duchenne Muscular Dystrophy serving as a pilot site for rare disease validation of B-COMPASS.
• Heinrich-Heine University DüsseldorfcoreStrategic or Co-development PartnerGerman university hospital conducting B-COMPASS validation studies, including presentation at Congress of European Rhinology Society.
• Tilburg UniversitycoreStrategic or Co-development PartnerDutch academic partner conducting behavioral science research as part of the BEAMER consortium.
• Associacao Protectora dos Diabeticos de PortugalcoreStrategic or Co-development PartnerPortuguese diabetes patient organization serving as pilot site for endocrinology validation studies.
• Foundation for Biomedical Research and Innovation in Primary Care of MadridcoreStrategic or Co-development PartnerSpanish foundation conducting primary care-based validation studies for B-COMPASS in Madrid healthcare settings.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Mango Health: Mango Health is a patient adherence app combining medication reminders with rewards and health tracking. It serves a similar patient adherence use case as BEAMER but with a consumer-facing commercial model.
• Wellth: Wellth is a digital health platform that uses behavioral economics and financial incentives to improve patient adherence. It is comparable to BEAMER in its behavioral science approach to adherence but is commercially deployed.
• Propeller Health: Propeller Health is a digital therapeutics platform focused on respiratory medication adherence using connected inhalers and predictive analytics. It overlaps with BEAMER's adherence prediction and condition-specific digital therapeutic approach.
• AiCure: AiCure uses AI and computer vision to measure patient adherence in clinical trials and real-world settings. It is a direct peer to BEAMER's predictive adherence technology, serving pharma and clinical research customers.
• Medisafe: Medisafe is a digital medication adherence platform that uses reminders, adherence tracking, and patient engagement tools. Compared to BEAMER, it is commercially commercialized with a focus on patient-facing reminders rather than BEAMER's behavioral segmentation approach.

Broad incumbents

• Care Innovations (Intel): Care Innovations provides remote patient monitoring and chronic care management solutions. It is comparable to BEAMER in the RPM and patient engagement space, though it operates as a broader incumbent with commercial deployment.
• Omada Health: Omada Health is a broader digital chronic care platform offering virtual care for diabetes, hypertension, and musculoskeletal conditions. It addresses adherence as part of a comprehensive chronic disease management offering, comparable to BEAMER's multi-condition scope.

Emerging players

• Voluntis: Voluntis develops digital therapeutics for chronic conditions including diabetes and oncology. It is comparable to BEAMER in its disease-agnostic digital therapeutic framework and pharma partnership model.
• WellDoc: WellDoc is a digital therapeutics company focused on chronic disease management, particularly diabetes. It shares a digital therapeutic, adherence-supporting approach with BEAMER and serves similar pharma and payer customers.

Others

• Adherence Solutions: Adherence Solutions is a consultancy and service provider focused on medication adherence programs for pharma. It is comparable to BEAMER in domain focus but operates as a service organization rather than a technology vendor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/beamerproject
• YouTubeyoutube.com/@BEAMERProject
• LinkedInlinkedin.com/company/beamerproject

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BEAMER